PRESS RELEASE

StarDrop 5.4

Optibrium, a developer of software for drug discovery, has released version 5.4 of its StarDrop™ software platform.

The company says the new release offers enhanced features to guide the design of novel, safe and efficacious drugs by providing access to world-leading technologies for toxicity prediction and bioisosteric transformations. These new optional modules further extend StarDropÂ’s capabilities to intuitively target high-quality compounds in drug discovery, reducing the time and cost to deliver drug candidates with an improved chance of success.

The new Derek Nexus™ module for StarDrop, developed in collaboration with Lhasa Limited, provides knowledge-based predictions of the likelihood of a compound causing toxicity in more than 40 endpoints, including mutagenicity, carcinogenicity and hepatotoxicity.

Integrated with StarDrop’s Glowing Molecule™ visualisation, this new module guides the redesign of compounds to reduce the potential for toxicity, the company says. An easy-to-use reporting feature facilitates collaboration between chemists and expert toxicologists to interpret the results, enabling effective, timely decision-making regarding the prioritisation of chemistries early in the drug discovery process.

Company: 
Analysis and opinion
Feature

Robert Roe investigates some of the European projects focusing on preparing today’s supercomputers and HPC programmers for exascale HPC

Feature

The Jülich Supercomputing Centre (JSC) at Forschungszentrum Jülich in Germany has been operating supercomputers of the highest performance class since 1987. Tim Gillett talks to Norbert Attig and Thomas Eickermann

Feature

Gemma Church investigates how simulation and modelling de-risks the detection and extraction of geothermal energy resources

Feature

Robert Roe investigates the importance of upgrading legacy laboratory informatics systems and the benefits this provides to scientists